These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2950318)

  • 1. Structure and functions of gp 140, the C3d/EBV receptor (CR2) of human B lymphocytes.
    Frade R
    Mol Immunol; 1986 Nov; 23(11):1249-53. PubMed ID: 2950318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
    Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
    J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor.
    Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP
    Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
    J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Fingeroth JD; Weis JJ; Tedder TF; Strominger JL; Biro PA; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4510-4. PubMed ID: 6087328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor.
    Frade R; Barel M; Ehlin-Henriksson B; Klein G
    Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1490-3. PubMed ID: 2983347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes.
    Barel M; Fiandino A; Delcayre AX; Lyamani F; Frade R
    J Immunol; 1988 Sep; 141(5):1590-5. PubMed ID: 2842398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system.
    Marquart HV; Olesen EH; Johnson AA; Damgaard G; Leslie RG
    Scand J Immunol; 1997 Sep; 46(3):246-53. PubMed ID: 9315112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear localization of the Epstein-Barr virus/C3d receptor (CR2) in the human Burkitt B lymphoma cell, Raji.
    Gauffre A; Viron A; Barel M; Hermann J; Puvion E; Frade R
    Mol Immunol; 1992 Sep; 29(9):1113-20. PubMed ID: 1323059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes.
    Barel M; Vazquez A; Charriaut C; Aufredou MT; Galanaud P; Frade R
    FEBS Lett; 1986 Mar; 197(1-2):353-6. PubMed ID: 2936622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.